Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Fulgent Genetics CFO Paul Kim reports the withholding of shares to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On February 23, 2025, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reported a transaction involving common stock.
- A total of 733 shares were withheld to satisfy tax obligations related to the vesting of restricted stock units.
- The price per share for the transaction was $16.46.
- Following the transaction, Kim directly owns 200,788 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is related to tax obligations of an executive.
Key Dates
| Date | Description |
|---|---|
| February 23, 2023 | Date of grant of restricted stock units to Paul Kim. |
| February 27, 2023 | Original Form 4 filing date for the grant of restricted stock units. |
| February 23, 2025 | Date of the stock transaction (tax withholding). |
| February 25, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.